Excelsior Correspondent
SRINAGAR, July 28: J&K Bank in a major CSR initiative adopted at least 50 Hepatitis-C patients belonging to underprivileged section of society across the State for complete treatment of the disease.
The patients registered with Government Medical College (GMC), Srinagar included children, men and women who lack financial resources to meet the expenses required for complete treatment of the disease. The initiative is supported by CIPLA India Pvt. Ltd.
J&K Bank Chairman and CEO Mushtaq Ahmad announced this today on World Hepatitis Day, in presence of Principal GMC Prof Rafiq Ahmad Pampori, prominent gastro-entrologists from SKIMS Dr. G N Yattoo, Dr. Gul Javaid and CIPLA representative Amit Kumar at a function held here at Bank’s Corporate Headquarters.
Bank’s senior presidents Vagish Chander, Abdul Rauf Bhat, S S Sehgal, presidents, vice-president and senior officers of the bank, besides dozens of Hepatitis-C patients were also present on the occasion.
Speaking on the occasion, Chairman said, “Since our CSR Department identified this critical health area for intervention that called for an immediate attention, we took the initiative instantly. And in the spirit of corporate social responsibility we reached an understanding with one of the top Pharma Companies of the country CIPLA for providing the world-class but affordable medicines for these patients. I thank CIPLA for coming forward voluntarily to meet this emerging health challenge in the State.”
Extending his heartfelt gratitude towards J&K Bank, Dr Pampori said that the bank’s CSR activities had received a real shot in arm under the Chairmanship of Mushtaq Ahmad.
Enunciating the reasons to support the Bank’s CSR initiative, CIPLA’s representative at the function, Amit Kumar said “Since J&K Bank is the most credible public institution of the State, we joined hands with them to make our intervention meaningful and effective”, he added.
Dr. Gul Javaid and Dr. Yattoo also lauded the bank’s adoption of Hepatitis-C patients and threw light on the disease. Notably, the bank along with CIPLA India Pvt. Ltd. will provide complete treatment support to the adopted patients; the cost of which in average terms ranges between Rs 90,000 to Rs 1,00,000 per patient.
Follow our WhatsApp channel